These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 1375851
1. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein. Uckun FM, Haissig S, Ledbetter JA, Fidler P, Myers DE, Kuebelbeck V, Weisdorf D, Gajl-Peczalska K, Kersey JH, Ramsay NK. Blood; 1992 Jun 15; 79(12):3369-79. PubMed ID: 1375851 [Abstract] [Full Text] [Related]
2. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation. Waddick KG, Uckun FM. Exp Hematol; 1993 Jun 15; 21(6):791-8. PubMed ID: 7684704 [Abstract] [Full Text] [Related]
3. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NK. Blood; 1992 Feb 15; 79(4):1094-104. PubMed ID: 1531306 [Abstract] [Full Text] [Related]
4. Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Uckun FM, Kersey JH, Vallera DA, Ledbetter JA, Weisdorf D, Myers DE, Haake R, Ramsay NK. Blood; 1990 Nov 01; 76(9):1723-33. PubMed ID: 2224122 [Abstract] [Full Text] [Related]
5. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia. Uckun FM, Chelstrom LM, Irvin JD, Finnegan D, Gunther R, Young J, Kuebelbeck V, Myers DE, Houston LL. Blood; 1992 May 15; 79(10):2649-61. PubMed ID: 1375109 [Abstract] [Full Text] [Related]
11. Multiparameter flow cytometric analysis of human fetal bone marrow B cells. LeBien TW, Wörmann B, Villablanca JG, Law CL, Steinberg LM, Shah VO, Loken MR. Leukemia; 1990 May 15; 4(5):354-8. PubMed ID: 1697009 [Abstract] [Full Text] [Related]
12. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. Hurwitz CA, Gore SD, Stone KD, Civin CI. Leukemia; 1992 Apr 15; 6(4):233-9. PubMed ID: 1375301 [Abstract] [Full Text] [Related]
17. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Uckun FM, Manivel C, Arthur D, Chelstrom LM, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers DE, Gunther R. Blood; 1992 May 01; 79(9):2201-14. PubMed ID: 1373967 [Abstract] [Full Text] [Related]
18. Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. Myers DE, Irvin JD, Smith RS, Kuebelbeck VM, Uckun FM. J Immunol Methods; 1991 Feb 15; 136(2):221-37. PubMed ID: 1705571 [Abstract] [Full Text] [Related]
19. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. Punnonen J, Aversa GG, Vandekerckhove B, Roncarolo MG, de Vries JE. J Immunol; 1992 Jun 01; 148(11):3398-404. PubMed ID: 1375243 [Abstract] [Full Text] [Related]
20. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF. Haematologica; 1998 Dec 01; 83(12):1069-75. PubMed ID: 9949623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]